News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Adcock Richard
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/07/2023 |
4
| Adcock Richard (CEO & President) has filed a Form 4 on ImmunityBio, Inc.|
Txns:
| Paid exercise price by delivering 42,192 shares
@ $4.33, valued at
$182.7k
Exercised 83,333 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Adcock Richard (CEO & President) has filed a Form 4 on ImmunityBio, Inc.|
Txns:
| Paid exercise price by delivering 4,273 shares
@ $5.07, valued at
$21.7k
Exercised 8,620 restricted stock units
@ $0 |
|
| 03/25/2022 |
4
| Adcock Richard (CEO & President) has filed a Form 4 on ImmunityBio, Inc.|
Txns:
| Granted 350,000 options to buy
@ $5.83, valued at
$2M
|
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Adcock Richard (CEO) has filed a Form 4 on NantKwest, Inc.|
Txns:
| Paid exercise price by delivering 68,171 shares
@ $23.72, valued at
$1.6M
Granted 750,000 options to buy
@ $23.72, valued at
$17.8M
Granted 250,000 restricted stock units
@ $0
Granted 150,000 restricted stock units
@ $0
Exercised 150,000 restricted stock units
@ $0 |
|
| 10/29/2020 |
3
| Adcock Richard (CEO) has filed a Form 3 on NantKwest, Inc. |
|
|